Rescheduling Marijuana: A Crucial Step to Support Our Troops
The conversation around medical marijuana rescheduling has regained momentum in recent months, drawing notable support from conservatives. Currently classified as...
CASE Op-Ed in DC Journal: Senate Bill Will Close Tax Loophole on Foreign Lawsuit Funders
The lack of regulation surrounding third-party litigation funding (TPLF) creates a significant legal loophole that could allow hedge funds, foreign...
CASE Reiterates Opposition to Foreign Price Controls and Urges Senators to Protect American Innovation
Alexandria, Virginia, June 9, 2025 – Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy (CASE), issued the...
CASE submits comment to FCC opposing mandatory transition to NextGen TV Standard
In response to the Federal Communications Commission’s request for public comment on the proposed use of the “Next Generation” Broadcasting...
CASE Comment to “DELETE, DELETE, DELETE”
(Alexandria, Virginia) — In response to FCC Chairman Brendan’ Carr opening a new docket seeking public comments “on every rule,...
CASE Op-Ed in DC Journal: Trump Has Fewer Than 30 Days to Keep Promise on Flavored Vapes
President Trump rescinded his predecessor’s proposed ban on menthol cigarettes less than a week after taking office. This delighted...
CASE Supports New Jersey Legislators Enforcing Price Transparency for Hospitals
Today, CASE announces support for new legislation introduced in New Jersey aimed at addressing the rapidly rising health care costs burdening...
CASE Op-Ed in RealClearHealth: CMS Rule on Weight-Loss Drugs Would Reduce Healthcare Costs Along With Waistlines
As many well know, America has a persistent – and rising – epidemic of obesity. According to the Centers for...
CASE Op-Ed in RealClearMarkets: DOJ’s Attack on Visa Mistakes Monopoly for Innovation
The Durbin Amendment, part of the Dodd-Frank Act, was supposed to promote competition by capping interchange fees for payment networks...
CASE Op-Ed in the Daily Signal: The Misguided Agenda of Biden’s Overreaching Federal Trade Commission Chair
The voters have spoken—they are ready for change. Tired of government overspending, overregulation, and excessive economic intervention, the American people...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/